Photronics Q3 Results Show Margin Gain, Cautious Q4

Photronics Q3 results beat guidance as high-end IC demand lifted margins; trimmed capex and a wide Q4 range signal near-term positioning risk for investors.

August 26, 2026·2 min read
View all news articles
Flat vector photomask wafer with expanding circuit pattern symbolizing Photronics Q3 results and margin gain.

KEY TAKEAWAYS

  • Q3 revenue $216 million beat guidance and Street expectations.
  • Gross margin widened to 33.2% while high-end IC reached a record 44% of IC revenue.
  • Q4 guidance range $207-$227 million flags limited visibility amid memory and fab-utilization risks.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Photronics, Inc. (NASDAQ: PLAB) reported fiscal third-quarter results on Aug. 26, showing revenue of $216.0 million, up 2.7% year over year and 2.9% sequentially. Management attributed the gains to recovering semiconductor design releases delayed from the prior quarter and stronger demand for high-end integrated circuit (IC) photomasks, which helped expand margins. Executives warned that memory supply, geopolitical tensions, and fabrication plant (fab) utilization risks cloud the outlook for the fourth quarter.

Q3 Results and Margins

For the quarter ended Aug. 2, Photronics said revenue exceeded the high end of prior guidance and topped Street expectations. Gross margin widened to 33.2%, and operating margin reached 21.1%, driven by favorable product mix and operating leverage. GAAP net income attributable to shareholders was $28.9 million, with diluted earnings per share (EPS) of $0.49. Adjusted net income was $29.4 million, and non-GAAP diluted EPS was $0.50.

Segment results showed IC revenue of $154.7 million, rising 5% year over year and sequentially, while flat-panel-display (FPD) revenue declined 2% on both bases to $61.4 million. The high-end IC photomask business reached a record 44% of total IC revenue, supporting margin expansion amid stronger demand for advanced-node and AI-related chips.

Guidance, Cash Flow, and Capital Spending

Photronics guided fiscal fourth-quarter revenue to a range of $207 million to $227 million, with operating margin between 19% and 24%, and non-GAAP diluted EPS from $0.40 to $0.56. The company cited limited visibility due to memory-market conditions, geopolitical risks, and fab utilization dynamics.

At quarter-end, Photronics held $672.8 million in cash, cash equivalents, and short-term investments, including $503.5 million in majority-owned joint ventures where it holds 50.01%. Operating cash flow for the quarter was $76.3 million, about 35% of revenue, while capital expenditures totaled $37.0 million. Year to date, operating cash flow reached $220.6 million on $130.4 million of capex. Management lowered full-year capital expenditure guidance to $255 million–$305 million from a prior $330 million, describing debt levels as very low relative to cash.

Management emphasized ongoing strength in high-end IC photomasks, including those for AI and advanced-node applications, while noting softness in the display segment. The company’s cautious capex approach reflects a measured calibration of internal extreme ultraviolet (EUV) capacity expansion amid uncertain memory demand, geopolitical tensions, and fab utilization changes. External analysis noted that although the quarter beat revenue and earnings estimates, Photronics’ low single-digit revenue growth trails broader semiconductor sector gains despite improved margins and cash generation.

Quote

“Our fiscal third quarter results reflect the recovery of some of the semiconductor design releases that were delayed and pushed out of our fiscal second quarter,” management said on the earnings call.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Nvidia Earnings Test AI Demand After PCE, GDP

Nvidia Earnings Test AI Demand After PCE, GDP

Nvidia earnings will test AI-driven revenue as July PCE stayed elevated and US GDP remained modest, potentially shifting near-term market flows.

Revolution Medicines FDA Approval Clears Rasonque

Revolution Medicines FDA Approval Clears Rasonque

Revolution Medicines FDA approval cleared RASONQUE for previously treated metastatic pancreatic cancer, boosting near-term investor positioning.

Boston Scientific Cyberattack Disrupts Shipments

Boston Scientific Cyberattack Disrupts Shipments

Boston Scientific cyberattack halted order processing and shipments, creating revenue and fulfillment risk as restoration timing remains unknown.

Semtech Earnings Show Record Q2 Revenue

Semtech Earnings Show Record Q2 Revenue

Semtech earnings beat on record Q2 sales and $0.71 adjusted EPS as AI data-center demand lifts margins and firms near-term growth positioning.

Kohl's Earnings Show Profit Lift From Tariff Refunds

Kohl's Earnings Show Profit Lift From Tariff Refunds

Kohl's earnings show profit and wider margins after tariff refunds while sales slipped, lifting EPS guidance and supporting near-term buybacks and returns

SpaceX Stock Faces Split Over AI Valuation

SpaceX Stock Faces Split Over AI Valuation

SpaceX stock faces analyst split after strong Starlink and AI growth; heavy AI capex and negative cash flow force traders to reassess Cursor upside.